We are live on ! Find out more
ASTX

ASTEX PHARMACEUTICALS, INC COM
ASTX

Delisted

ASTX was delisted on the 10th of October, 2013.

Back to rankings

Fund managers haven’t disclosed any holdings of ASTX yet.

ASTX Hedge Fund Activity: Q4 2013 in Review

0 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in ASTEX PHARMACEUTICALS, INC COM (ASTX) for Q4 2013, worth a combined $0 — down 100% from $487M a quarter earlier.

Sellers outnumbered buyers: 123 funds closed out of ASTX and 0 opened new positions — a net loss of 123 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock Fund Advisors, exiting entirely with an estimated $35.4M sold.

  • 0 institutional investors held ASTEX PHARMACEUTICALS, INC COM (ASTX) as of Q4 2013, down from 123 in Q3 2013.
  • Funds reported $0 of ASTEX PHARMACEUTICALS, INC COM stock for Q4 2013, down 100% quarter-over-quarter.
  • 0 funds opened new ASTEX PHARMACEUTICALS, INC COM positions in Q4 2013 and 123 closed out, a net change of -123 holders.
  • The largest ASTEX PHARMACEUTICALS, INC COM seller in Q4 2013 was BlackRock Fund Advisors, an estimated $35.4M sold.

Based on aggregated 13F filings for Q4 2013.